Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.53 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.53 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
| ▸ | PIM1 | P11309 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | CASP6 | P55212 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21756078 | 0.90 | MAPT (0.47) | CSNK2A2CSNK2BCSNK2A1MAPTMAPK1 | |
| SCHEMBL23693655 | 0.90 | CSNK2A2 (0.49) | CSNK2A2CSNK2BCSNK2A1MAPTMAPK1 | |
| SCHEMBL19217398 | 0.89 | CSNK2A2 (0.62) | CSNK2A2CSNK2BCSNK2A1MAPTMAPK1 | |
| SCHEMBL258689 | 0.87 | PIM1 (0.55) | CSNK2A2CSNK2BCSNK2A1MAPTMAPK1 | |
| SCHEMBL1610145 | 0.87 | MAPT (0.50) | CSNK2A2CSNK2BCSNK2A1MAPTMAPK1 | |
| SCHEMBL16925876 | 0.84 | ESR2 (0.52) | CSNK2A2CSNK2BCSNK2A1MAPTMAPK1 | |
| SCHEMBL10144943 | 0.83 | CSNK2A2 (0.41) | CSNK2A2CSNK2BCSNK2A1MAPTMAPK1 | |
| SCHEMBL1637246 | 0.82 | PIM1 (0.52) | CSNK2A2CSNK2BCSNK2A1MAPTMAPK1 | |
| SCHEMBL19155599 | 0.82 | MAPT (0.47) | CSNK2A2CSNK2BCSNK2A1MAPTMAPK1 | |
| SCHEMBL22271444 | 0.82 | MAPT (0.47) | CSNK2A2CSNK2BCSNK2A1MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11744152-B2 | Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications | UDC IRELAND LIMITED (IE) | 2023-08-29 | — | — | US | disclosed |
| EP-3368520-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2023-04-26 | — | — | EP | disclosed |
| WO-2021147882-A1 | DIBENZOFURAN DERIVATIVE CATHEPSIN K INHIBITOR, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | 深圳信立泰药业股份有限公司 | 2021-07-29 | — | — | WO | disclosed |
| WO-2021121230-A1 | COMPOUND, APPLICATION THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING SAME | 北京鼎材科技有限公司 | 2021-06-24 | — | — | WO | disclosed |
| EP-3835299-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | LG Chem, Ltd. (KR) | 2021-06-16 | — | — | EP | disclosed |
| EP-3345983-B1 | COMPOUNDS CONTAINING AT LEAST ONE DISILYL COMPOUND SELECTED FROM DISILYLCARBAZOLES, DISILYLDIBENZOFURANS, DISILYLDIBENZOTHIOPHENES, DISILYLDIBENZOPHOSPHOLES, DISILYLDIBENZOTHIOPHENE S-OXIDES AND DISILYLDIBENZOTHIOPHENE S, S-DIOXIDES | UDC IRELAND LTD (IE) | 2020-08-26 | — | — | EP | disclosed |
| EP-3318566-B1 | AZADIBENZOFURANS FOR ELECTRONIC APPLICATIONS | UDC IRELAND LTD (IE) | 2020-06-24 | — | — | EP | disclosed |
| EP-3061759-B1 | NITRILE SUBSTITUTED DIBENZOFURANS | IDEMITSU KOSAN CO (JP) | 2019-12-25 | — | — | EP | disclosed |
| EP-3174885-B1 | 2,9-FUNCTIONALIZED BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLES AS HOSTS FOR ORGANIC LIGHT EMITTING DIODES (OLEDS) | IDEMITSU KOSAN CO (JP) | 2019-10-02 | — | — | EP | disclosed |
| EP-2993215-B1 | Azabenzimidazo[2,1-a]benzimidazoles for electronic applications | IDEMITSU KOSAN CO (JP) | 2019-06-19 | — | — | EP | disclosed |
| US-20160248026-A1 | NITRILE SUBSTITUTED DIBENZOFURANS | IDEMITSU KOSAN CO., LTD. (JP) | 2016-08-25 | — | — | US | disclosed |
| US-20160190480-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | BASF SE (DE) | 2016-06-30 | — | — | US | disclosed |
| US-20150243907-A1 | AZADIBENZOFURANS FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2015-08-27 | — | — | US | disclosed |
| US-20150207083-A1 | BENZIMIDAZO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2015-07-23 | — | — | US | disclosed |
| US-8962779-B2 | Method of forming polyaryl polymers | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-02-24 | — | — | US | disclosed |
| US-20150031847-A1 | METHOD OF FORMING POLYARYL POLYMERS | DOW GLOBAL TECHNOLOGIES LLC | 2015-01-29 | — | — | US | disclosed |
| US-20140252280-A1 | 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2014-09-11 | — | — | US | disclosed |
| US-20120241681-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | BASF SE (DE) | 2012-09-27 | — | — | US | disclosed |
| US-7323458-B1 | Dihydrobenzodiazepins and their use for treating dyslipidemia | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2008-01-29 | — | — | US | disclosed |
| US-7323458-B1 | Dihydrobenzodiazepins and their use for treating dyslipidemia | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2008-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120241681-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | EIF4A1, ITPR2, ITPR1 | CSNK2A2 389/4885CSNK2B 1050/4885CSNK2A1 312/4885 |
| US-20150243907-A1 | AZADIBENZOFURANS FOR ELECTRONIC APPLICATIONS | AZI2, BRPF1, CCNB1 | CSNK2A2 1937/4885CSNK2B 2110/4885CSNK2A1 1992/4885 |
| US-11744152-B2 | Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications | PAICS, EIF4A1, ECI1 | CSNK2A2 725/4885CSNK2B 1523/4885CSNK2A1 611/4885 |
| US-20160190480-A1 | 4H-Imidazo[1,2-a]imidazoles for Electronic Applications | PAH, NISCH, KCNH1 | CSNK2A2 1294/4885CSNK2B 2391/4885CSNK2A1 1317/4885 |
| US-20160248026-A1 | NITRILE SUBSTITUTED DIBENZOFURANS | DBF4, NXF1, NCF1 | CSNK2A2 2789/4885CSNK2B 2324/4885CSNK2A1 2151/4885 |
| US-20150207083-A1 | BENZIMIDAZO[1,2-A]BENZIMIDAZOLE DERIVATIVES FOR ELECTRONIC APPLICATIONS | PAICS, EIF4A1, ECI1 | CSNK2A2 725/4885CSNK2B 1523/4885CSNK2A1 611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.